LPAR1 and systemic sclerosis: Specifically, links between LPA signaling through its receptor LPA1 have long been established in preclinical models of IPF and systemic sclerosis,12, 13, 14 with LPA1‐deficient mice protected from fibrosis in bleomycin models of lung and dermal fibrosis.12, 14